Document is current
Any future updates will be listed below
-
Authors
Bosc, Elodie
Anastasie, Julie
Soualmia, Feryel
Coric, Pascale https://orcid.org/0000-0001-8484-1381
Kim, Ju Youn
Wang, Lily Q.
Lacin, Gullen
Zhao, Kaitao https://orcid.org/0000-0003-3331-5263
Patel, Ronak
Duplus, Eric
Tixador, Philippe
Sproul, Andrew A.
Brugg, Bernard
Reboud-Ravaux, Michelle
Troy, Carol M. https://orcid.org/0000-0003-1312-7441
Shelanski, Michael L.
Bouaziz, Serge
Karin, Michael
El Amri, Chahrazade
Jacotot, Etienne D. https://orcid.org/0000-0002-5301-1569
- License Information
-
More Information
Article History
Received: 3 December 2021
Revised: 26 October 2022
Accepted: 1 November 2022
First Online: 15 November 2022
Competing interests
: E.J. is the inventor of a patent titled “Novel derivatives and their use as selective inhibitors of Caspase-2” (WO/2017/162674). E.J. and E.B. are inventors of a patent titled “Novel compounds and their use as selective inhibitors of Caspase-2” WO/2019/068538. M.K. and J.Y.K. hold a patent on mouse models for the treatment of NASH, M.K. is a founder of Elgia Pharmaceuticals and has received research support from Jansen and Gossamer Bio.
